Benefit of magnesium sulfate given before very preterm birth to protect infant brain [9]

Pediatrics

Volumn 121, Issue 1, 2008, Pages 225-226

  Marret, Stéphane ^a   Marpeau, Loïc ^a   Bénichou, Jacques ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM SULFATE;

BRAIN PROTECTION; CEREBRAL PALSY; COGNITIVE DEFECT; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; FETUS; HUMAN; INFANT; INFANT MORTALITY; LETTER; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; PREMATURITY; PRIORITY JOURNAL; SINGLE DRUG DOSE; TREATMENT OUTCOME;

BRAIN DISEASES; DELIVERY, OBSTETRIC; DEVELOPMENTAL DISABILITIES; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; INFUSIONS, INTRAVENOUS; MAGNESIUM SULFATE; MALE; ODDS RATIO; PREGNANCY; PREMATURE BIRTH; PROBABILITY; REFERENCE VALUES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 38049091949     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2007-2971     Document Type: Letter

References (5)

1. 4) Collaborative Group. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA. 2003;290:2669-2676
2. Marret S, Marpeau L, Zupan-Simunek V, et al. Magnesium sulphate given before very-preterm birth to protect infant brain: the randomised controlled PREMAG trial. BJOG. 2007;114:310-318
3. Amiel-Tison C, Gosselin J. Neurological Development From Birth to 6 Years: User Manual and Examination Chart. Baltimore, MD: John Hopkins University Press; 2001
4. Frankenburg WK, Dodds J, Archer P, Shapiro H, Bresnick B. The Denver II: a major revision and restandardization of the Denver Developmental Screening Test. Pediatrics. 1992;89:91-97
5. Saudino KJ, Dale PS, Oliver B, et al. The validity of parent-based assessment of the cognitive abilities of 2-year-olds. Br J Dev Psychol. 1998;16:349-363